Study of AVE5026 at Weight-adjusted Doses in Children With a Central Venous Line

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01567904
Recruitment Status : Terminated (Decision from Sanofi to withdraw on a worldwide basis the Marketing Authorisation Applications for Semuloparin sodium in the adult indication)
First Posted : March 30, 2012
Last Update Posted : May 3, 2016
Information provided by (Responsible Party):

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : July 2012
  Actual Study Completion Date : July 2012
  Certification/Extension First Submitted : April 4, 2016